MAGEA4 is known to mediate stabilization of RAD18 through inhibiting its ubiquitin-dependent proteolysis and promoting trans-lesion synthesis in the adenocarcinoma cell line H1299 (Gao et al, 2016). This evidence concerns the gene MAGEA4 and adenocarcinoma.